Emily Faucette

Investor Relations Contact chez TALIS BIOMEDICAL CORPORATION

Health Technology

Consumer Services

Postes actifs de Emily Faucette

Sociétés	Poste	Début	Fin
TALIS BIOMEDICAL CORPORATION	Investor Relations Contact	01/01/2021	-
TALIS BIOMEDICAL CORPORATION	Public Communications Contact	01/01/2021	-

Sociétés	Poste	Début	Fin
PORTOLA PHARMACEUTICALS, INC.	Investor Relations Contact	01/02/2020	01/07/2020
GENOMIC HEALTH, INC.	Investor Relations Contact	-	-
GENOMIC HEALTH, INC.	Public Communications Contact	-	-

American University

Undergraduate Degree

Internationale

Etats-Unis

Opérationnelle

Investor Relations Contact	3
Public Communications Contact	2
Undergraduate Degree	1

Sectorielle

Health Technology	4
Consumer Services	2

Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Sociétés cotées	1
TALIS BIOMEDICAL CORPORATION	Health Technology

Entreprise privées	2
Genomic Health, Inc. Genomic Health, Inc. Medical SpecialtiesHealth Technology Genomic Health, Inc. engages in the provision of genomic-based diagnostic tests. Its tests analyze the underlying biology of cancers, allowing physicians and patients to make individualized treatment decisions. The firm uses a platform which translates a massive amount of clinical and genomic data into clinically actionable results for treatment planning. The company was founded by Patrick F. Terry, Joffre B. Baker, Randal W. Scott, and Steven Shak in August 2000 and is headquartered in Redwood City, CA.	Health Technology
Portola Pharmaceuticals LLC Portola Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Portola Pharmaceuticals, Inc. engaged in the development and commercialization of novel therapeutics in the areas of thrombosis, other hematologic disorders, and inflammation. It offers Andexxa and Bevyxxa medicines. The company was founded by Charles J. Homcy and David R. Philips on September 2, 2003 and is headquartered in South San Francisco, CA.	Health Technology

Entreprise privées

Health Technology